ArsenalBio Refocuses on In-Vivo CAR-T and Reduces Workforce

Company: ArsenalBio · Event Type: Strategic Pivot + Workforce Reduction · New Focus: In-Vivo CAR-T (Hematologic Malignancies, Autoimmunity) · Date: August 31, 2026 Summary ArsenalBio is shifting its primary focus from clinical autologous solid-tumor cell therapies to in-vivo CAR-T programs spanning hematologic malignancies, autoimmunity and…